Fixed-ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin

  1. Vilsbøll, T.
  2. Blevins, T.C.
  3. Jodar, E.
  4. Poulter, N.
  5. Tentolouris, N.
  6. Ross Agner, B.F.
  7. Lehmann, L.
  8. Leiter, L.A.
Aldizkaria:
Diabetes, Obesity and Metabolism

ISSN: 1463-1326,  1462-8902

Argitalpen urtea: 2019

Alea: 21

Zenbakia: 6

Orrialdeak: 1506-1512

Mota: Artikulua

DOI: 10.1111/DOM.13675 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus